Interleukin-17 modulates uPA and MMP2 expression in human periodontal ligament mesenchymal stem cells: involvement of the ERK1/2 MAPK pathway

Authors

  • Ivana Okić Đorđević Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia https://orcid.org/0000-0003-3552-1546
  • Tamara Kukolj Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia
  • Hristina Obradović Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia https://orcid.org/0000-0003-4626-7184
  • Drenka Trivanović 1. Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia; 2. IZKF Research Group for Tissue Regeneration in Musculoskeletal Diseases, University Clinics, Würzburg, Germany; 3. Bernhard-Heine-Center for Locomotion Research, University Würzburg, Germany https://orcid.org/0000-0001-7041-3917
  • Andjelija Petrović Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia
  • Slavko Mojsilović Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia
  • Maja Miletić Faculty of Dental Medicine, University of Belgrade, Doktora Subotića 8, 11000 Belgrade, Serbia https://orcid.org/0000-0002-8622-7171
  • Diana Bugarski Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia
  • Aleksandra Jauković Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, Doktora Subotića 4, 11129 Belgrade, Serbia https://orcid.org/0000-0003-2686-7481

DOI:

https://doi.org/10.2298/ABS210929048O

Keywords:

interleukin-17, periodontal ligament mesenchymal stem cells (PDLMSC), urokinase-type plasminogen activator (uPA), metalloproteinase (MMP), extracellular signal-regulated kinase (ERK)1/2, mitogen-activated protein kinase (MAPK) signaling pathway

Abstract

Paper description:

  • Proinflammatory cytokine IL-17 regulates the expression of extracellular proteolytic enzymes in multiple cell types. We investigated whether it contributes to periodontal ligament remodeling and tissue destruction.
  • The influence of IL-17 on urokinase-type plasminogen activator (uPA) and metalloproteinase (MMP) MMP2/MMP9 gene and protein expression in periodontal ligament mesenchymal stem cells (PDLMSCs) was investigated by RT-PCR, Western and zymography analyses.
  • IL-17 stimulates uPA and matrix MMP-2 gene and protein expression through activation of the extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein (MAP) kinase signaling pathway.
  • IL-17 contributes to extracellular degradation in the periodontal ligament and it could be involved in periodontal disease pathogenesis.

Abstract: Periodontal disease is a chronic infection of periodontal tissue characterized by extracellular matrix (ECM) degradation due to increased expression of plasminogen activators and matrix metalloproteinases (MMPs) and various proinflammatory cytokines, including interleukin (IL)-17. Successful regeneration of damaged periodontal tissues depends on the proper functionality of periodontal ligament mesenchymal stem cells (PDLMSCs), especially the production of extracellular matrix proteases. We investigated the influence of IL-17 on ECM remodeling through modulation of urokinase-type plasminogen activator (uPA) and MMP2/MMP9 expression in human PDLMSCs at mRNA, protein and activity levels using by RT-PCR, Western blotting and zymography, respectively. Investigation of the involvement of MAPKs in these processes in PDLMSCs was determined by Western blotting, as well as by utilizing specific p38 and MEK1/2 inhibitors. Our results show that IL-17 activates MAPK signaling in PDLMSCs. Moreover, IL-17 had no effect on MMP9 expression, but it stimulated uPA and MMP2 gene and protein expression in PDLMSCs through the activation of the ERK1/2 MAPK signaling pathway. The obtained data suggest that IL-17 contributes to ECM degradation in the periodontal ligament by stimulating uPA and MMP2 expression and activity in PDLMSCs. This information is important for understanding periodontal disease development and defining future directions of its treatment.

Downloads

Download data is not yet available.

References

Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809-20. https://doi.org/10.1016/S0140-6736(05)67728-8

Seo BM, Song IS, Um S, Lee JH. Periodontal Ligament Stem Cells. Stem Cell Biol Tissue Eng Dent Sci. 2015;291-6. https://doi.org/10.1016/B978-0-12-397157-9.00024-2

Stechmiller J, Cowan L, Schultz G. The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds. Biol Res Nurs. 2010;11(4):336-44. https://doi.org/10.1177/1099800409346333

Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen. 1996;4(3):321-5. https://doi.org/10.1046/j.1524-475X.1996.40307.x

Corotti M V., Zambuzzi WF, Paiva KBS, Menezes R, Pinto LC, Lara VS, Granjeiro JM. Immunolocalization of matrix metalloproteinases-2 and -9 during apical periodontitis development. Arch Oral Biol. 2009;54(8):764-71. https://doi.org/10.1016/j.archoralbio.2009.04.013

Paula-Silva FWG, da Silva LAB, Kapila YL. Matrix Metalloproteinase Expression in Teeth with Apical Periodontitis Is Differentially Modulated by the Modality of Root Canal Treatment. J Endod. 2010;36(2):231-7. https://doi.org/10.1016/j.joen.2009.10.030

Daci E, Everts V, Torrekens S, Van Herck E, Tigchelaar-Gutterr W, Bouillon R, Carmeliet G. Increased Bone Formation in Mice Lacking Plasminogen Activators. J Bone Miner Res. 2003;18(7):1167-76. https://doi.org/10.1359/jbmr.2003.18.7.1167

Wyganowska-Świ̧atkowska M, Surdacka A, Skrzypczak-Jankun E, Jankun J. The plasminogen activation system in periodontal tissue (Review). Int J Mol Med. 2014;33(4):763-8. https://doi.org/10.3892/ijmm.2014.1653

Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z, Bagby G, Nelson S, Kolls JK. Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis. J Immunol. 2000;164(9):4783-9. https://doi.org/10.4049/jimmunol.164.9.4783

Jovčić G, Bugarski D, Krstić A, Vlaški M, Petakov M, Mojsilović S, Stojanović N, Milenković P. The effect of interleukin-17 on hematopoietic cells and cytokine release in mouse spleen. Physiol Res. 2007;56(3):331-9. https://doi.org/10.33549/physiolres.930944

Kotake S, Yago T, Kawamoto M, Nanke Y. Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: Crucial "human osteoclastology". J Bone Miner Metab. 2012;30(2):125-35. https://doi.org/10.1007/s00774-011-0321-5

Zhao L, Zhou Y, Xu Y, Sun Y, Li L, Chen W. Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients. J Clin Periodontol. 2011;38(6):509-16. https://doi.org/10.1111/j.1600-051X.2011.01712.x

Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10(7):479-89. https://doi.org/10.1038/nri2800

Reynolds JM, Angkasekwinai P, Dong C. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev 2010;21(6):413-23. https://doi.org/10.1016/j.cytogfr.2010.10.002

Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14(9):585-600. https://doi.org/10.1038/nri3707

Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM, Lee Y, Kim H-H. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: Implications for bone remodeling. Cell Death Differ. 2009;16(10):1332-43. https://doi.org/10.1038/cdd.2009.74

Cardoso CR, Garlet GP, Crippa GE, Rosa AL, Júnior WM, Rossi MA, Silva JS. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009;24(1):1-6. https://doi.org/10.1111/j.1399-302X.2008.00463.x

Oseko F, Yamamoto T, Akamatsu Y, Kanamura N, Iwakura Y, Imanishi J, Kita M. IL-17 is involved in bone resorption in mouse periapical lesions. Microbiol Immunol. 2009;53(5):287-94. https://doi.org/10.1111/j.1348-0421.2009.00123.x

Shimizu M, Yamaguchi M, Fujita S, Utsunomiya T, Yamamoto H, Kasai K. Interleukin-17/T-helper 17 cells in an atopic dermatitis mouse model aggravate orthodontic root resorption in dental pulp. Eur J Oral Sci. 2013;121(2):101-10. https://doi.org/10.1111/eos.12024

Đordević IO, Kukolj T, Krstić J, Trivanović D, Obradović H, Santibañez JF, Mojsilović S, Ilić V, Bugarski D, Jauković A. The inhibition of periodontal ligament stem cells osteogenic differentiation by IL-17 is mediated via MAPKs. Int J Biochem Cell Biol. 2016;71:92-101. https://doi.org/10.1016/j.biocel.2015.12.007

Cheng G, Wei L, Xiurong W, Xiangzhen L, Shiguang Z, Songbin F. IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-κB and AP-1 activation. Cell Mol Neurobiol. 2009;29(8):1161-8. https://doi.org/10.1007/s10571-009-9409-z

Starodubtseva NL, Sobolev V V., Soboleva AG, Nikolaev AA, Bruskin SA. Genes expression of metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis. Russ J Genet. 2011;47(9):1117-23. https://doi.org/10.1134/S102279541109016X

Kocić J, Santibañez JF, Krstić A, Mojsilović S, Ilić V, Bugarski D. Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase. Int J Biochem Cell Biol. 2013;45(2):464-75. https://doi.org/10.1016/j.biocel.2012.11.010

Gaffen SL. An overview of IL-17 function and signaling. Cytokine. 2008;43(3):402-7. https://doi.org/10.1016/j.cyto.2008.07.017

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. https://doi.org/10.1080/14653240600855905

Miletić M, Mojsilović S, Okić-Dordević I, Kukolj T, Jauković A, Santibañez JF, Jovčić G, Bugarski D. Mesenchymal stem cells isolated from human periodontal ligament. Arch Biol Sci. 2014;66(1):261-71. https://doi.org/10.2298/ABS1401261M

Villar V, Kocic J, Bugarski D, Jovcic G, Santibanez JF. SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes. FEBS Lett. 2010;584(22):4586-92. https://doi.org/10.1016/j.febslet.2010.10.020

Santibanez JF, Guerrero J, Quintanilla M, Fabra A, Martinez J. Transforming growth factor-b1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun. 2002;296:267-73. https://doi.org/10.1016/S0006-291X(02)00864-1

Faust D, Schmitt C, Oesch F, Oesch-Bartlomowicz B, Schreck I, Weiss C, Dietrich C. Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts. Cell Commun Signal. 2012;10:6. https://doi.org/10.1186/1478-811X-10-6

Shaker OG, Ghallab NA. IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: Relation to PCR bacterial detection. Mediators Inflamm. 2012;2012:174764. https://doi.org/10.1155/2012/174764

Vernal R, Dutzan N, Chaparro A, Puente J, Valenzuela MA, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol. 2005;32(4):383-9. https://doi.org/10.1111/j.1600-051X.2005.00684.x

Trivanović D, Jauković A, Popović B, Krstić J, Mojsilović S, Okić-Djordjević I, Kukolj T, Obradović H, Santibanez JF, Bugarski D. Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression. Life Sci. 2015 15;141:61-73. https://doi.org/10.1016/j.lfs.2015.09.019

Miletić M, Mojsilović S, Okić-Đorđević Ivana, Kukolj Tamara, Jauković Aleksandra, Santibaсez JF, Jovčić G, Bugarski D. Mesenchymal stem cells isolated from human periodontal ligament. Arch Biol Sci. 2014;66(1):261-71. https://doi.org/10.2298/ABS1401261M

Wang Y, Wu H, Wu X, Bian Z, Gao Q. Interleukin 17A promotes gastric cancer invasiveness via NF-κB mediated matrix metalloproteinases 2 and 9 expression. PLoS One. 2014;9(6):1-6. https://doi.org/10.1371/journal.pone.0096678

Li G, Zhang Y, Qian Y, Zhang H, Guo S, Sunagawa M, Hisamitsu T, Liu Y. Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α pathway. Mol Immunol. 2013;53(3):227-36. https://doi.org/10.1016/j.molimm.2012.08.018

Wu Y, Zhu L, Wei H, Peng B. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts. J Endod. 2013;39(1):62-7. https://doi.org/10.1016/j.joen.2012.09.025

Krstić J, Obradović H, Jauković A, Okić-Dordević I, Trivanović D, Kukolj T, Mojsilović S, Ilić V, Santibañez JF, Bugarski D. Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration. Biochim Biophys Acta - Mol Cell Res. 2015;1853(2):431-44. https://doi.org/10.1016/j.bbamcr.2014.11.025

Phinney DG. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy. J Cell Biochem. 2012;113(9):2806-12. https://doi.org/10.1002/jcb.24166

Gaffney J, Solomonov I, Zehorai E, Sagi I. Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo. Matrix Biol. 2015;44-46:191-9. https://doi.org/10.1016/j.matbio.2015.01.012

Cheng WC, Hughes FJ, Taams LS. The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol. 2014;41(6):541-9. https://doi.org/10.1111/jcpe.12238

Zhu L, Wu Y, Wei H, Xing X, Zhan N, Xiong H, Peng B. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways. Mol Immunol. 2011;48(4):647-56. https://doi.org/10.1016/j.molimm.2010.11.008

Kapila YL, Kapila S, Johnson PW. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol. 1996;15(4):251-61. https://doi.org/10.1016/S0945-053X(96)90116-X

Legrand C, Polette M, Tournier JM, De Bentzmann S, Huet E, Monteau M, Birembaut P. uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp Cell Res. 2001;264(2):326-36. https://doi.org/10.1006/excr.2000.5125

Marzena W-Ś, Surdacka A, Skrzypczak-Jankun E, Jankun J. The plasminogen activation system in periodontal tissue (Review). Int J Mol Med. 2014;33(4):763-8. https://doi.org/10.3892/ijmm.2014.1653

Lam RS, O'Brien-Simpson NM, Hamilton JA, Lenzo JC, Holden JA, Brammar GC, Orth RK, Tan Y, Walsh KA, Fleetwood AJ, Reynolds EC. GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model. Immunol Cell Biol. 2015;93(8):705-15. https://doi.org/10.1038/icb.2015.25

Downloads

Published

2022-04-01

How to Cite

1.
Okić Đorđević I, Kukolj T, Obradović H, Trivanović D, Petrović A, Mojsilović S, Miletić M, Bugarski D, Jauković A. Interleukin-17 modulates uPA and MMP2 expression in human periodontal ligament mesenchymal stem cells: involvement of the ERK1/2 MAPK pathway. Arch Biol Sci [Internet]. 2022Apr.1 [cited 2024Apr.20];74(1):15-24. Available from: https://serbiosoc.org.rs/arch/index.php/abs/article/view/7089

Issue

Vol. 74 No. 1 (2022)

Section

Articles

License

Copyright (c) 2021 Archives of Biological Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.